-
Lisinopril Dihydrate: Research Workflow Guide
2026-08-16
Lisinopril dihydrate provides a water-compatible, nanomolar ACE inhibition tool for modeling renin–angiotensin signaling across cardiovascular and renal experiments. This guide translates its biochemical profile into practical dose-response workflows, disease-model readouts, selectivity controls, and troubleshooting decisions.
-
G007-LK: Tankyrase 1/2 Inhibitor Workflow
2026-08-15
G007-LK provides a practical way to connect tankyrase activity with AXIN stabilization, β-catenin turnover, and Wnt pathway output in cancer models. This workflow-focused guide covers APC-mutant colorectal systems, Hippo/YAP-linked hepatocellular carcinoma assays, dosing strategy, and common troubleshooting points.
-
Maraviroc (A8311) for Reliable CCR5 Assays
2026-08-14
Learn how Maraviroc (SKU A8311) can improve CCR5-focused viability, proliferation, and viral-entry workflows through careful solvent control, assay selection, and data interpretation. This scenario-based guide connects HIV-1 entry inhibition with emerging inflammatory applications while distinguishing established evidence from practical laboratory recommendations.
-
Dimetridazole: Mechanism, Fate, and Assay Design
2026-08-14
Dimetridazole, also known as 1,2-Dimethyl-5-nitroimidazole, is more than an antimicrobial assay reagent. This evidence-led guide connects its microbial effects with hydroxyl-radical degradation, transformation-product toxicity, redox sensing, and better decisions in bacterial culture assay and infection model research.
-
Sodium Picosulfate in Gut–Brain Assays
2026-08-13
Sodium Picosulfate offers a controllable chemical perturbation for epithelial, hepatic, stool-output, and gut–liver–brain experiments. This guide translates its formulation data and recent neuroinflammation-imaging evidence into practical workflows, controls, and troubleshooting strategies without confusing exploratory research with clinical treatment.
-
In Vitro Drug Responses: Viability, Arrest, and Death
2026-08-13
Hannah R. Schwartz’s 2022 dissertation separates relative viability from fractional viability to clarify whether an anticancer treatment primarily stops proliferation, induces cell death, or does both. Its central practical contribution is a more discriminating framework for interpreting drug-response assays, especially when growth inhibition and killing occur with different magnitudes and timing.
-
Dovitinib (TKI-258): RTK Signaling in Cancer Research
2026-08-12
Dovitinib (TKI-258) is a multitargeted receptor tyrosine kinase inhibitor with low-nanomolar activity against FLT3, c-Kit, FGFR, VEGFR, and PDGFR family members. Its reported suppression of ERK and STAT signaling supports apoptosis induction in cancer cells, while the supplied prostate cancer circRNA study provides a separate, hypothesis-generating framework rather than direct Dovitinib evidence.
-
Ceapin-A7 for ATF6α ER Stress Research
2026-08-12
Use Ceapin-A7 to isolate the ATF6α branch from PERK-driven stress signaling in cell-based ER stress models. This workflow translates recent nucleus pulposus cell findings into controlled experiments that connect unfolded protein response modulation with pyroptosis and JAK1–STAT3 activity.
-
Faropenem sodium in Reliable Cell Assays
2026-08-11
Learn how Faropenem sodium (SKU C8712) can be incorporated into reproducible cell viability, proliferation, cytotoxicity, and antimicrobial workflows. This scenario-based guide covers formulation, controls, concentration planning, interpretation, and practical supplier-selection criteria.
-
Topotecan HCl: Applied Cancer Research Workflows
2026-08-11
Topotecan HCl enables mechanism-led studies of replication-associated DNA damage across lung, breast, and prostate cancer models. This guide pairs practical dosing and formulation advice with a more rigorous separation of growth inhibition from true cell killing.
-
From Pathway to Phenotype: AO/PI in Kidney Research
2026-08-10
A translational framework for connecting diabetic nephropathy mechanism studies with rigorous viability measurement using AO/PI Staining Solution and fluorescence-based cell counting.
-
Calpeptin as a Mechanistic EV Release Probe
2026-08-09
Calpeptin is a potent calpain inhibitor that can help dissect extracellular-vesicle release, cell-to-cell signaling, and assay confounding. This article connects TNBC EV research with more cautious applications in fibrosis and inflammation studies.
-
Phosbind Biotin LC: PVDF Detection Guide
2026-08-08
Phosbind Biotin LC is a phosphate-binding reagent for detecting phosphorylated proteins on PVDF membranes when phospho-specific antibodies are unavailable, unsuitable, or limited by sequence context. It is intended for Western Blot workflows using streptavidin-HRP and chemiluminescence, not aqueous-only protocols or long-term storage of prepared solutions.
-
AO/PI Staining Solution for Viability Workflows
2026-08-07
AO/PI Staining Solution combines acridine orange and propidium iodide to separate intact, membrane-compromised, and impurity-rich samples during fluorescence-based cell counting. This practical workflow shows how to use the reagent in diabetic nephropathy and cytotoxicity studies while avoiding common errors in sample preparation, timing, and interpretation.
-
Peripheral Macrophages Drive Pain Priming in Sleep Apnea Mod
2026-08-07
Chivers et al. reveal that peripheral macrophage recruitment and signaling underlie persistent nociceptor priming in a mouse model of chronic intermittent hypoxia—a physiological analog of obstructive sleep apnea. Their findings clarify immune contributions to pain comorbidities in sleep-disordered breathing, suggesting new intervention targets for OSA-associated chronic pain.